Yale scientists develop 'gas gauge' to prevent pregnancy lossAugust 03, 2009New Haven, Conn. - To combat the many fetal deaths that occur annually because the placenta is too small, researchers at Yale School of Medicine have developed a method to measure the volume of the placenta, which provides nourishment to the fetus. Limits in current technology keep doctors from being able to monitor the growth of the placenta, which, like the gas tank of a car, is the source of fuel for the fetus. The placenta can be so small that the fetus literally runs out of food and oxygen and dies, according to lead author Harvey J. Kliman, M.D., a research scientist in the Department of Obstetrics, Gynecology and Reproductive Sciences. He and his colleagues published the results of their findings in the August 3 issue of the American Journal of Perinatology. Fetal death, or intrauterine fetal demise (IUFD), affects 30,000 women each year in the United States. Until now, there has been no easy way to determine how much "gas" is left in the placenta's tank. Kliman decided to study this issue after noting that many late-term pregnancy losses were associated with very small placentas. He theorized that in much the same way that an obstetrician uses ultrasounds to follow the growth of the fetus, or a pediatrician weighs and measures children to ensure they are growing normally, the growth of the fetus' placenta could be monitored. When Kliman asked perinatologists (maternal fetal medicine specialists) why they did not look at the placenta when performing routine ultrasounds, the answer was always the same: The placenta is a curved structure and is too difficult to measure. If they had to measure the placental volume they would need a very expensive machine, specialized training and more time. With the help of his father, Merwin Kliman, a mathematician and electrical engineer, Kliman developed an equation that used the maximal width, height and thickness of the placenta. Kliman and his team at Yale then validated the method by comparing the volume predicted by the Estimated Placenta Volume (EPV) equation taken just before delivery to the actual weight of the placenta at the time of delivery. "In this study, we showed that the equation predicted the actual placental weight with an accuracy of up to 89 percent," said Kliman. "The method works best during the second and early third trimesters, just when routine ultrasound screening is done on many women in the U.S." In addition to validating the equation, the team is also collecting EPV data from centers around the world to create the normative curves that doctors can use to determine if the placenta is normal, too small or even too big. "I hope that the EPV test becomes routine for pregnant women," said Kliman. Yale University |
|||||||||||||||||||||
| Related Placenta Current Events and Placenta News Articles New research shows versatility of amniotic fluid stem cells For the first time, scientists have demonstrated that stem cells found in amniotic fluid meet an important test of potential to become specialized cell types, which suggests they may be useful for treating a wider array of diseases and conditions than scientists originally thought. U of M researchers find 2 units of umbilical cord blood reduce risk of leukemia recurrence A new study from the Masonic Cancer Center, University of Minnesota shows that patients who have acute leukemia and are transplanted with two units of umbilical cord blood (UCB) have significantly reduced risk of the disease returning. Lessons from flu seasons past Pregnant women who catch the flu are at serious risk for flu-related complications, including death, and that risk far outweighs the risk of possible side effects from injectable vaccines containing killed virus, according to an extensive review of published research and data from previous flu seasons. Placental precursor stem cells require testosterone-free environment to survive Trophoblast stem cells (TSCs), cells found in the layer of peripheral embryonic stem cells from which the placenta is formed, are thought to exhibit "immune privilege" that aids cell survivability and is potentially beneficial for cell and gene therapies. NIH launches 2009 H1N1 influenza vaccine trials in HIV-infected pregnant women The first clinical trials to test whether the 2009 H1N1 influenza vaccine can safely elicit a protective immune response in pregnant women launched yesterday, and a trial to conduct the same test in HIV-infected children and youth will begin next week. Eating liquorice in pregnancy may affect a child's IQ and behavior Expectant mothers who eat excessive quantities of liquorice during pregnancy could adversely affect their child's intelligence and behaviour, a study has shown. Scientists discover key factor in regulating placenta and fetal growth Scientists funded by the Biotechnology and Biological Sciences Research Council (BBSRC) have shown that a common biological protein molecule called SHP-2 is crucial for encouraging placenta growth. Mother's immune system may block fetal treatments for blood diseases Pediatric researchers have resolved an apparent contradiction in the field of prenatal cell transplantation- a medical approach that holds future promise in correcting sickle cell disease and other serious congenital blood disorders. Stem cell research: From molecular physiology to therapeutic applications Stem cell research promises remedies to many devastating diseases that are currently incurable, ranging from diabetes and Parkinson's disease to paralysis. Experimental treatment halts hypoxic-ischemic brain injury in newborns Inhibiting an enzyme in the brains of newborns suffering from oxygen and blood flow deprivation stops a type of brain damage that is a leading cause of cerebral palsy, mental retardation and death, according to researchers at Cincinnati Children's Hospital Medical Center. More Placenta Current Events and Placenta News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||